Zentek Ltd.

Zentek Ltd.

0.62
CAD
-0.02
(-3.12%)
-0.10EPS
78.50MMarket Cap
Nov 16Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
Basic EPS, GAAP
-0.06
-0.05
-0.07
-0.05
-0.02
-0.04
-0.02
-0.05
-0.34
-0.14
-0.12
-0.1
-0.09
-0.1
Free Cash Flow per Basic Share
-0.04
-0.02
-0.03
-0.03
-0.02
-0.02
-0.02
-0.02
-0.13
-0.15
-0.08
-0.06
-0.05
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.38
0.36
0.36
0.36
0.35
0.33
0.32
0.32
0.42
0.31
0.2
0.14
0.09
0.2
Tangible Book Value per Share
0.38
0.36
0.36
0.36
0.35
0.33
0.32
0.32
0.42
0.31
0.2
0.14
0.09
0.2
Basic Weighted Avg Shares
54
56
60
62
63
67
77
84
92
99
101
103
106
109
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-3,528.46
-20,112.48
-40,174.8
-1,100.37
-5,981.22
-9,427.75
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
Net Income, GAAP
-4
-3
-4
-3
-2
-2
-2
-4
-32
-14
-12
-10
-10
-10
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-9,330.95
-19,784.87
-39,254.06
-1,150.68
-5,882.61
-9,652.83
Working Capital
2
- -
- -
1
- -
1
1
1
30
16
4
1
-1
14
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
- -
2
2
Total Equity
21
20
21
23
22
25
26
27
42
30
20
15
10
25
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-18.81
-14.56
-20.05
-12.86
-6.99
-10.34
-6.09
-14.55
-91.85
-40.08
-46.3
-57.5
-79.57
-53.24

Capital Structure

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
107
108
127
Market Capitalization
100
78
79

Working Capital

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
3
2
18
Cash, Cash Equivalents & STI
2
1
17
Accounts Receivable, Net
- -
- -
- -
Inventories
1
- -
- -
Total Current Liabilities
3
4
4
Payables & Accruals
3
3
4
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.37%
-13.92%
-33.54%
Free Cash Flow
46.45%
84.47%
-19.3%
Net Income, GAAP
72.15%
125.8%
-2.71%
Sales/Revenue/Turnover
- -
- -
-80.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
1
1
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.03
-0.03
-0.02
-0.02
-0.1
2026
-0.01
-0.02
-0.02
-0.03
-0.09
2027
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Mohammed Jiwan
Full Time Employees
10
Sector
Process industries
Industry
Chemicals: major diversified
Address
1123 York Rd Guelph ON Canada N1E 6Z1
IPO Date
Dec 15, 2010
Website
zentek.com
Business
Zentek Ltd. is a Canadian intellectual property development and commercialization company specializing in advanced nanomaterials, primarily graphene-based technologies. The company’s core products and services include graphene materials derived from its Albany graphite deposit; graphene-based antimicrobial coatings marketed under the ZenGUARD™ brand; surgical masks; HVAC filters enhanced with graphene-silver technology; personal protective equipment; rapid detection point-of-care diagnostic tests; pharmaceutical products based on graphene compounds; and research and development in graphene oxide synthesis and aptamers. Zentek operates through wholly owned subsidiaries, including Albany Graphite Corp., focusing on the purification and commercial exploitation of graphite, targeting markets in healthcare, biotechnology, and high-technology industrial sectors across Canada, the United States, the Middle East, India, and South America. Founded in 2008 and headquartered in Guelph, Ontario, Zentek has transitioned from mineral exploration to a technology commercialization focus emphasizing healthcare applications and advanced materials. Recent major developments include a strategic CEO transition with Mohammed Jiwan appointed as CEO in November 2025; the announcement of a novel Graphite Gel-Based Fire-Retardant product called GraphGel™, along with an exclusive U.S. licensing agreement with Altek Advanced Materials Inc. for commercial distribution in the U.S. market; expansion of ZenGUARD™ Enhanced Air Filters demonstrating significant infectious aerosol removal efficiency; and a non-exclusive licensing letter of intent with Altek for U.S. commercialization rights. Zentek’s Albany Graphite Corp. subsidiary achieved ultra-high purity graphite (5N, 99.9992%) meeting nuclear industry standards, supporting high-tech applications. The company also strengthened its global footprint through partnerships enabling production and marketing in Gulf Cooperation Council countries and secured funding and operational expansions focusing on commercialization of proprietary nanotechnologies within healthcare prevention, detection, and treatment segments.

Company News

  • Zentek Announces New Additions to Team and Management Change

  • Zentek Invited to Present Albany Graphite Purification Results at the 26th International Nuclear Graphite Specialists Meeting

  • Zentek Ships First Government of Canada Order of ZenGUARD(TM) Enhanced Air Filters

  • Zentek (NASDAQ:ZTEK) vs. VNET Group (NASDAQ:VNET) Head-To-Head Contrast

  • Zentek Files Technical Report for the Albany Graphite PEA: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to Ultra-High-Purity Graphite

  • Zentek Pre-Qualifies Under Canada's Defence Drone Initiative Marketplace

  • Zentek Provides Corporate Update

  • Zentek Ltd. Begins Trading on OTCQX Best Market

  • Zentek Approved for Trading on the OTCQX Best Market

  • Zentek Corrects Day of Week for OTC Markets Trading Start Date

  • Zentek Provides Update on Nasdaq Listing

  • Zentek Awarded Government of Canada Standing Offer for HVAC Filters

  • Zentek Files Provisional Patent Application for Absorption-Based EMI Shielding Coating Made from Albany Graphite

  • Zentek Announces New PEA for Albany Graphite: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to 99.9992% Purity Graphite

  • Zentek retient les services d'IMPAQ Capital inc. afin d'accroître sa visibilité auprès des investisseurs en Amérique du Nord

  • Zentek Engages IMPAQ Capital Inc. to Broaden Investor Awareness Across North America

  • Zentek Engages Atrium Research Corporation For Company-Sponsored Research Coverage

  • Zentek's ZenGUARD(TM) Enhanced Air Filtration Media Completes Qualification Program with Quality Filters Inc.; First U.S. Commercial Order Received

  • Zentek Establishes Pathway to Sell ZenGUARD(TM) Enhanced Air Filtration Media in the U.S.

  • Zentek Forms U.S. Joint Venture to Position Its Albany Ultra-High-Purity Graphite in the North American National-Security Supply Chain